BioSpace News Archive

Business

Cybin Partners With Worldwide Clinical Trials to Support Future Clinical Development of CYB003 in Major Depressive Disorder

Cybin Inc. today announced that it has partnered with Worldwide Clinical Trials (“Worldwide”), a global, full-service contract research organization (“CRO”) with deep expertise managing clinical trials for mental health conditions, including major depressive disorder.

July 26, 2023
·
7 min read
Business

Intercept to Announce Second Quarter 2023 Financial Results on August 2, 2023

Intercept Pharmaceuticals, Inc. will announce its second quarter 2023 financial results on Wednesday, August 2, 2023.

July 26, 2023
·
1 min read
Business

Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023

Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023.

July 26, 2023
·
1 min read
Business

ExThera Medical in Growth Mode after FDA Approval of Investigational Device Exemption

ExThera Medical Corporation today announces the addition of Michael DiMeo as Chief Financial Officer.

July 26, 2023
·
5 min read
Business

Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8

Establishment Labs Holdings Inc. plans to announce its financial results for the quarter ended June 30, 2023, after the market closes on Tuesday, August 8, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.

July 26, 2023
·
2 min read
Bio NC

Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases

Kriya Therapeutics, Inc. today announced the addition of over $150 million in capital committed as part of its Series C Financing, bringing the total Series C round to over $430 million.

July 26, 2023
·
2 min read
Business

Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023

Allogene Therapeutics, Inc. today announced that it will report second quarter 2023 financial results on Wednesday, August 2, 2023, after the close of the market.

July 26, 2023
·
1 min read
Business

Sarepta Therapeutics to Announce Second Quarter 2023 Financial Results

Sarepta Therapeutics, Inc. will report second quarter 2023 financial results after the Nasdaq Global Market closes on Wednesday, August 2, 2023.

July 26, 2023
·
1 min read
Biotech Beach

Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference

Exagen Inc., a leading provider of autoimmune testing solutions, announced its participation in the Canaccord Genuity 43rd Annual Growth Conference, which takes place August 7-10, 2023, at the InterContinental Boston Hotel in Boston, MA.

July 26, 2023
·
3 min read
Drug Development

Tonix Pharmaceuticals Announces Accelerating Completion of Enrollment in Phase 2 UPLIFT Study of TNX-601 ER (Racemic Tianeptine) for Major Depressive Disorder: Topline Data Now Expected in Fourth Quarter 2023

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, announced that development of TNX-4300*, the single -isomer of tianeptine will be prioritized over TNX-601 ER*, which is being studied in the Phase 2 UPLIFT1 trial for the treatment of major depressive disorder.

July 26, 2023
·
20 min read